NKO
Natural health product licensed in Canada
- Other names
- OCEANO3
- Licence holder
- Biodroga Nutraceuticals Inc.
- NPN or DIN-HM
- 80061016
- Status
- Active licence
- Licence date
- 19 May 2015
- Revision date
- 17 March 2023
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de krill Source : Euphausia superba - en entier Potency : 150 mg Eicosapentaenoic acid | 1,000 mg | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 90 mg Docosahexaenoic acid | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 300 mg Omega-3 Fatty acids | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 420 mg Phospholipids | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 0.9 mg Esterified astaxanthin | Not specified | Not calculated |
Non-medicinal ingredients
Glycérol, Ethylvanilline, Sorbitol, Gélatine, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 1 Tous les jours |
| Adultes et adolescents | minimum: 9 years ; maximum: 17 years | 1 Capsule | 1 Tous les jours |
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
| Adultes de sexe féminin | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
1- source of omega-3 fatty acids for the maintenance of good health. 2- source of EPA and DHA for the maintenance of good health. 3- Helps to relieve symptoms of dysmenorrhea and premenstrual syndrome. 4- Helps to relieve symptoms of premenstrual syndrome. 5- Helps to maintain cardiovascular health. 6- In conjunction with conventional statin therapy, helps to reduce serum triglycerides/triacylglycerols. 7- In conjunction with conventional statin therapy, helps to reduce the levels of LDL cholesterol. 8- In conjunction with conventional statin therapy, helps to increase the levels of HDL cholesterol. 9- Helps to support/maintain eye health/function. 10- Helps to support/maintain visual health/function. 11-Helps to support/maintain normal brain function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80061016
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.